China Medical System Holdings of Shenzhen acquired China rights to two Novartis drugs: Lamisil, an antifungal medication used especially for fingernail and toenail infections, and Parlodel, a dopamine agonist that treats pituitary-caused disorders. The agreement includes rights to manufacture the drugs and a joint marketing license for the Swiss market in addition to the China rights. Financial details were not disclosed.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
